TGA grant Moderna vaccine provisional registration for 12-17 years

The Therapeutic Goods Administration (TGA) has provisionally approved (PA) the use of the Moderna Australia Pty Ltd COVID-19 vaccine SPIKEVAX (elasomeran) in individuals 12 to 17 years.[1]

Previously on August 9, 2021, the TGA granted Spikevax PA for use in individuals aged 18 years and older.